miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN

Jiahong Xu1, Yu Tang1, Yihua Bei2

  • 1Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.

Oncotarget
|February 27, 2016
PubMed

Insights

Myocardial ischemia-reperfusion (I-R) injury treatment is limited. This study reveals miR-19b protects heart cells by reducing apoptosis, suggesting miR-19b therapy for I-R injury.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Stress Response

Background:

  • Myocardial ischemia-reperfusion (I-R) injury presents significant therapeutic challenges.
  • The miR-17-92 microRNA cluster is implicated in cell proliferation and apoptosis, but its role in I-R injury is unclear.

Purpose of the Study:

  • To investigate the role of the miR-17-92 cluster, specifically miR-19b, in myocardial I-R injury.
  • To determine the therapeutic potential of modulating miR-19b in the context of I-R injury.

Main Methods:

  • Utilized a murine model of myocardial I-R injury and H2O2-treated H9C2 cardiomyocytes to mimic oxidative stress.
  • Employed flow cytometry and Western blot analysis to assess apoptosis, cell survival, and protein expression.
  • Investigated the regulatory relationship between miR-19b and its downstream target, PTEN.

Main Results:

  • miR-19b was significantly downregulated in the infarct area of I-R injured hearts and in H2O2-treated cardiomyocytes.
  • Overexpression of miR-19b reduced apoptosis and enhanced cell survival under oxidative stress.
  • PTEN was identified as a direct downstream target of miR-19b, mediating its protective effects against apoptosis.

Conclusions:

  • miR-19b plays a protective role in mitigating myocardial I-R injury by inhibiting apoptosis.
  • PTEN is a key mediator in the miR-19b pathway during oxidative stress in cardiomyocytes.
  • miR-19b represents a potential novel therapeutic target for treating myocardial I-R injury.

Related Concept Videos